You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API clonidine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing clonidine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp CATAPRES clonidine 21695-567 MINERAL OIL
Rebel Distributors Corp CATAPRES clonidine 21695-567 SILICON DIOXIDE
TruPharma LLC CLONIDINE clonidine 52817-375 CELLULOSE, MICROCRYSTALLINE
TruPharma LLC CLONIDINE clonidine 52817-375 CROSPOVIDONE
TruPharma LLC CLONIDINE clonidine 52817-375 HYPROMELLOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing clonidine

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc clonidine 0378-0871 MINERAL OIL
Mylan Pharmaceuticals Inc clonidine 0378-0871 SILICON DIOXIDE
XGen Pharmaceuticals DJB Inc clonidine 39822-2000 SODIUM CHLORIDE
Ingenus Pharmaceuticals LLC clonidine 50742-247 CELLULOSE, MICROCRYSTALLINE
Ingenus Pharmaceuticals LLC clonidine 50742-247 HYPROMELLOSE 2208
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for clonidine

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIUM CHLORIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CALCIUM PHOSPHATE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: EDETATE DISODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL PALMITATE

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MINERAL OIL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYISOBUTYLENE

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ACETATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM POLYSTYRENE SULFONATE

Excipient focus: SODIUM SILICATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

clonidine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Actavis Pharma Inc clonidine hydrochloride 0228-2127
NCS HealthCare of KY LLC dba Vangard Labs clonidine hydrochloride 0615-2572
NCS HealthCare of KY LLC dba Vangard Labs clonidine hydrochloride 0615-2574
NCS HealthCare of KY LLC dba Vangard Labs clonidine hydrochloride 0615-8272
Major Pharmaceuticals clonidine hydrochloride 0904-5656
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, CORN

Excipient focus: STARCH, POTATO

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCROSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: VINYL ACETATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group